THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$190.77
-1.09 (-0.57%)
▼
5d:
-6.21%
30d:
-20.31%
90d:
-4.9%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
THC is down 4.7% this week, but smart money is accumulating calls. Top strike: $220 2026-05-15 with 522 OI. Call ratio: 90% View Scanner →
Strength: 6.4/10
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: THC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: THC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$252.76
Based on 3.2% avg growth
INTRINSIC VALUE TODAY
$156.95
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $190.77, which is considered oversold relative to its 30-day fair value range of $204.70 to $240.47. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.9) compared to its historical average (12.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This pessimistic expectation contrasts with the company's recent 27.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, THC is in a uptrend. The price is currently testing key support at $191.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $261.38 (+36.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, THC is in a uptrend. The price is currently testing key support at $191.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (28th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $261.38 (+36.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$204.70 -
$240.47
Company Quality Score
60/100
(BUY)
Options IV Signal
28th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
83.5%
Protect Your Profits
Holding THC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 28th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.2% below Wall St target ($261.38)
- CAUTION: Recommendation downgraded due to -6.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$204.70 -
$240.47
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$12.64
(6.6%)
Support & Resistance Levels
Support Level
$191.96
Resistance Level
$229.21
Current Trend
Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.93
Wall Street Target
$261.38
(+36.2%)
Revenue Growth (YoY)
8.9%
Earnings Growth (YoY)
27.6%
Profit Margin
6.6%
Valuation Discount vs History
-4.0% cheaper
PE vs Historical
10.9 vs 12.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.0%
(market-implied from PE analysis)
1-Year Target
$184.19
(-4%)
2-Year Target
$176.82
(-8%)
3-Year Target
$169.75
(-12%)
3-Yr Target (if PE normalizes)
(PE: 11→12)
$191.06
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 2.4%)
$422.32
(+120%)
Base:
(SPY PE: 10.9, Growth: 2.4%)
$206.03
(+7%)
Bear:
(PE: 9.3, Growth: 2.4%)
$175.13
(-9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 12.93 | Current EPS (TTM): $15.49
Bull Case
$249.79
(+23%)
Analyst growth 13.3%, PE expands to 14.2
Base Case
$227.08
(+12%)
Market implied 13.3%, PE stable at 12.9
Bear Case
$136.24
(-33%)
Severe decline -20.0%, PE contracts to 11.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.9 to 12.3
Stabilization Target:
$215.95
(+12.6%)
PE Expansion Potential:
+12.6%
Share & Embed Analysis
Last updated: March 30, 2026 10:13 AM ET
Data refreshes hourly during market hours. Next update: 11:13 AM
Data refreshes hourly during market hours. Next update: 11:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
UHS
Universal Health Service… |
HOLD
19 analysts |
$249 | 60 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$29 | 55 HOLD |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
